Engineering structure-controlled aging ovarian organoid to explore immune modulation
Biomedical Engineering Communications · 2026 · 5 (6) · 33
DOI: 10.53388/bmec2026033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2026. Verfasst von Pei-Jie Yu und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Ovarian aging impairs fertility and endocrine homeostasis, a process accelerated by chemotherapy. However, mechanistic studies have been limited by the absence of physiologically relevant ovarian organoid models that incorporate immune components.
Methods
We developed a long-lived, bilayer alginate ovarian organoid system from primary mouse granulosa and stromal cells, maintaining viability and functional markers for 45 days. By integrating splenic T cells, we further established an immune-competent ovarian organoid platform.
Results
Organoids derived from senescent cells recapitulated
Zitieren
APA
Yu, P., Liu, B., Li, X., Wu, Y., Li, T., Li, S., Tam, K., Liu, Y., Yang, M., Dong, C., & Chang, Y. (2026). Engineering structure-controlled aging ovarian organoid to explore immune modulation. Biomedical Engineering Communications, 5(6), 33. https://doi.org/10.53388/bmec2026033
Vancouver
Yu P, Liu B, Li X, Wu Y, Li T, Li S, et al. Engineering structure-controlled aging ovarian organoid to explore immune modulation. Biomedical Engineering Communications. 2026;5(6):33. doi:10.53388/bmec2026033
BibTeX
@article{Yu2026,
author = {Yu, Pei-Jie and Liu, Bin and Li, Xin-Can and Wu, Yun-Han and Li, Tong and Li, Si-Chun and Tam, King-Yeung and Liu, Yi and Yang, Mo and Dong, Cheng and Chang, Yun},
title = {Engineering structure-controlled aging ovarian organoid to explore immune modulation},
journal = {Biomedical Engineering Communications},
year = {2026},
volume = {5},
number = {6},
pages = {33},
doi = {10.53388/bmec2026033}
}
EUVIMED